Luye Pharma Group Receivables

Luye Pharma Group (LYPHF) currently reports a receivables of $3.3B as of June 2026. That compares with $3.5B in the prior-year period — down 6.5% year over year. Use the charts on this page to explore Luye Pharma Group's receivables history and peer comparisons.

Luye Pharma Group's receivables decreased from $3.5B to $3.3B — a 6.5% year-over-year decrease (period ending June 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Luye Pharma Group reported $3.3B in receivables as of June 2026. That compares with $3.5B in the prior-year period — down 6.5% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current receivables of $3.3B, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Luye Pharma Group, and consider following LYPHF for alerts when major investors trade the stock.